Figure 3

Correlations between duration mismatch negativity (dMMN) amplitude and the plasma level of glutamate at the electrode FCz in first-episode psychosis (FEP; left), ultra-high risk (UHR; middle), and healthy controls (HC; right).
Correlations between duration mismatch negativity (dMMN) amplitude and the plasma level of glutamate at the electrode FCz in first-episode psychosis (FEP; left), ultra-high risk (UHR; middle), and healthy controls (HC; right).